Title:
組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤
Document Type and Number:
Japanese Patent JP7399382
Kind Code:
B2
Abstract:
The invention relates to pharmaceutical compositions and dosage forms comprising full-length recombinant human parathyroid hormone (rhPTH(1-84)). The invention further relates to new and/or improved PTH compositions having improved in-use stability that are resistant to protein degradation in response to physical and chemical stresses.
Inventors:
Dixit, Nitin
Nguyen, Vin
Mouillac, Pierre
Bus, Stitt
Nguyen, Vin
Mouillac, Pierre
Bus, Stitt
Application Number:
JP2021503531A
Publication Date:
December 18, 2023
Filing Date:
July 12, 2019
Export Citation:
Assignee:
Takeda GmbH
International Classes:
A61K38/29; A61K9/08; A61K47/02; A61K47/10; A61K47/12; A61K47/18; A61K47/20; A61K47/22; A61K47/26; A61K47/34; A61P19/08; A61P19/10
Domestic Patent References:
| JP2015504087A |
Foreign References:
| WO2009053106A1 |
Attorney, Agent or Firm:
Hiroshi Higuchi
Kaoru Kawano
Kaoru Kawano